Fig. 2From: A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapyIncidence rate of ≥ grade 2 of radiation dermatitis in two treatment groupBack to article page